- EUROAPI is moving ahead with its FOCUS-27 plan, setting the foundations for future profitable growth1
- EUROAPI poursuit sa transformation grâce au plan FOCUS-27 et pose les bases d’une future croissance rentable1
- EUROAPI and Priothera enter into CDMO collaboration to advance oncology project
- EUROAPI et Priothera signent un accord de CDMO pour un projet en oncologie
- Market update : FOCUS-27 transformation project financing
- Information marché Financement du projet de transformation FOCUS-27
- EUROAPI reaches major Health IPCEI milestone with official notification from European Commission
- EUROAPI franchit une étape majeure du PIIEC Santé avec la notification officielle de la Commission européenne
- EUROAPI renforce sa présence en santé animale avec un contrat de fourniture de 130-150 millions d’euros
- EUROAPI strengthens its presence in animal health with a €130-150 million supply contract
More ▼
Key statistics
On Friday, Euroapi SA (EAPI:PAR) closed at 2.64, 16.81% above the 52 week low of 2.26 set on Mar 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.76 |
---|---|
High | 2.78 |
Low | 2.61 |
Bid | 2.62 |
Offer | 2.66 |
Previous close | 2.76 |
Average volume | 277.11k |
---|---|
Shares outstanding | 95.59m |
Free float | 62.69m |
P/E (TTM) | -- |
Market cap | 264.02m EUR |
EPS (TTM) | -2.01 EUR |
Data delayed at least 15 minutes, as of Jul 05 2024 16:39 BST.
More ▼